MET Alteration
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer (NCT07285148) | Beijing Pearl Biotechnology Limited Liability Company | 2026-06-01 |
| FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations (NCT06669117) | Pierre Fabre Medicament | 2024-10-22 |
| APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (NCT03175224) | Apollomics Inc. | 2017-09-27 |
Track MET Alteration automatically
Every clearance here is in the API, with alerts when new ones post.